Livingston, NJ, United States of America

Noah Laban Rosenberg

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Noah Laban Rosenberg: Innovator in Cardiovascular Treatments

Introduction

Noah Laban Rosenberg is a notable inventor based in Livingston, NJ (US). He has made significant contributions to the field of cardiovascular disease treatment through his innovative patents. With a total of 3 patents, Rosenberg's work focuses on fixed dose combinations that aim to improve patient outcomes.

Latest Patents

Rosenberg's latest patents include groundbreaking formulations that combine ETC1002 and ezetimibe. These compositions are designed to treat or reduce the risk of cardiovascular disease. The methods disclosed in these patents highlight the use of fixed doses of ETC-1002 and ezetimibe for treating cardiovascular conditions and hypercholesterolemia. Additionally, he has developed fixed dose combinations of ETC1002 and one or more statins, further enhancing treatment options for cardiovascular disease.

Career Highlights

Throughout his career, Rosenberg has worked with various organizations, including Esperion Therapeutics, Inc. His innovative approach to drug formulation has positioned him as a key figure in the development of cardiovascular therapies. His patents reflect a commitment to improving health outcomes for patients at risk of cardiovascular diseases.

Collaborations

Rosenberg has collaborated with notable professionals in the field, including Roger Schofield Newton and Diane Elaine MacDougall. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Noah Laban Rosenberg's contributions to cardiovascular treatment through his innovative patents demonstrate his dedication to improving patient care. His work continues to influence the field and offers promising solutions for those affected by cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…